Chari Smith

Chari Smith

Company: Kriya Therapeutics

Job title: VP, Research & Development, Metabolic Disease


Chari Smith is currently a Senior Program Leader for Kriya Therapeutics, developing gene therapies for Type 1 Diabetes and rare metabolic disorders.  Dr. Smith is the founder and principal consultant for PharmTeam Consulting, providing consulting services for preclinical drug discovery programs with a focus on projects emerging from academic environments. She recently served as the VP of Nonclinical Research at Metavant Sciences, a diabetes and metabolic disease-focused company.  Prior to Metavant, Dr. Smith spent 23 years in R&D at GSK, where she contributed to the development of therapies for Type 1 and Type 2 diabetes, HIV, preterm labor, HBV, and HSV.  For much of that time she was the director of the Cell Pharmacology Laboratory for the Metabolic and Antiviral Center of Excellence in Drug Discovery.  She also served as North American Biology Leader in GSK’s Discovery Partnerships with Academia program, initiating industry/academia collaborations in rare genetic diseases such as Cystic Fibrosis, FSHD and inherited childhood obesity.

Dr. Smith completed her postdoctoral fellowship in the department of Physiology at the UCLA Medical Center.  She holds a PhD in Biochemistry from Brandeis University, and a BA in Biology from Cornell University.

For contact information, please email


A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.